RANK expression on tumor cells furthermore promotes their migration to the bones, while inhibition of RANKL/RANK signaling resulted in reduced bone metastasis in an experimental breast cancer model (Figure 1) [171, 173]. Here, TNFRSF11A is linked to breast carcinoma.